Objective: To present prenatal diagnosis and molecular cytogenetic characterization of a small supernumerary marker chromosome (sSMC) derived from chromosome 8 by multiplex ligation-dependent probe amplification (MLPA), fluorescence in situ hybridization (FISH), spectral karyotyping (SKY) and array comparative genomic hybridization (aCGH). Case Report: A 42-year-old woman, gravida 6, para 3, underwent amniocentesis at 19 gestational weeks because of advanced maternal age. Amniocentesis revealed a de novo ring-shaped sSMC in all 13 colonies of the amniocytes. The karyotype was 47,XY,+mar. The MLPA showed duplications of 8p11.21-specific probes. At 24 gestational weeks, level II ultrasound revealed a left multicystic kidney in the fetus. Other internal organs were unremarkable. Repeat amniocentesis revealed a karyotype of 47,XY,+mar[25]/46,XY[2]. The sSMC was characterized by SKY and FISH, which showed a chromosome 8 origin of the sSMC. Oligonucleotide-based aCGH demonstrated a 4.4-Mb duplication of 8p11.21q11.1 [arr cgh 8p11.21q11.1 (42,637,062,180)×3]. The karyotype was 47,XY,+r(8) (p11.21q11.1)[25]/46,XY [2] . Polymorphic DNA marker analysis revealed no uniparental disomy for chromosome 8. The woman elected to continue the pregnancy and at 34 gestational weeks, a 1,820 g male baby without craniofacial dysmorphism was delivered. At the age of 1 month, the infant was apparently normal except for left multicystic kidney disease and mild ventriculomegaly. Conclusion: MLPA, SKY and aCGH are helpful in genetic counseling of prenatally detected sSMCs by providing the immediate information on the origin and the genetic contents of the sSMC. [Taiwan J Obstet Gynecol 2010; 49(4):500-505] 
Introduction
Small supernumerary marker chromosomes (sSMCs) are defined as structurally abnormal chromosomes that cannot be identified or characterized by conventional banding cytogenetics and are generally equal in size or smaller than a chromosome 20 [1] [2] [3] . The sSMCs are present in 0.044% of newborn infants and in 0.075% of prenatal cases [1, 3, 4] . Around 70% of sSMCs arise de novo [5] , and about 70% of sSMCs are derived from acrocentric chromosomes [1, 6] , and 70% of de novo sSMCs have no phenotypic effects [4] . Prenatal diagnosis of sSMCs gives rise to difficulties in genetic counseling, and requires molecular cytogenetic technologies to identify the nature of the aberrant chromosome [4, [7] [8] [9] [10] [11] .
Here we present our experience of prenatal diagnosis and molecular cytogenetic characterization of an sSMC derived from chromosome 8 by multiplex ligationdependent probe amplification (MLPA), fluorescence in situ hybridization (FISH), spectral karyotyping (SKY) and array comparative genomic hybridization (aCGH).
Case Report
A 42-year-old woman, gravida 6, para 3, underwent amniocentesis at 19 gestational weeks because of advanced maternal age. Amniocentesis revealed a ring-shaped sSMC in all 13 colonies of the amniocytes. The karyotype was 47,XY,+mar ( Figure 1 ). The parental karyotypes were normal. MLPA was applied to determine the origin of the sSMC using the SALSA MLPA Kit P181-A2/P182-B1 Centromere (MRC-Holland bv, Amsterdam, the Netherlands; Figure 2 ). The result of MLPA indicated a duplication of the 8p11.21-specific probe 05722-L05161 containing the FNTA gene and the 8p11.21-specific probe 06244-L06278 containing the HOOK3 gene. No duplication was found in the 8q11.21-specific probe 06239-L05745 (KIAA0146 gene) and the 8q11.21-specific probe 05757-L05195 (PRKDC gene). At 24 gestational weeks, level II ultrasound revealed a left multicystic kidney in the fetus. Other internal organs were unremarkable. Repeat amniocentesis revealed a karyotype of 47,XY,+mar [25] /46,XY [2] . The sSMC was characterized by SKY using 24-color SKY probes (Applied Spectral Imaging, Carlsbad, CA, USA) and FISH using a WCP8-specific gene probe (Cytocell, Adderbury, Oxfordshire, UK; Figures Polymorphic DNA marker analysis of the cultured amniocytes revealed no uniparental disomy for chromosome 8. The woman elected to continue the pregnancy and at 34 gestational weeks, a 1,820-g male baby without craniofacial dysmorphism was delivered by cesarean section because of maternal preeclampsia. At the age of 1 month, the infant had a weight of 2,090 g (< 3 rd centile) and a height of 43 cm (< 3 rd centile). He was apparently normal except for left multicystic kidney disease and mild ventriculomegaly. 
Discussion
Our presentation shows the usefulness of the MLPA Centromere kit, SKY and aCGH in the identification of an sSMC derived from chromosome 8. MLPA, first described by Schouten et al [12] , is a molecular method to detect gene dosage abnormalities in a wide range of conditions by relative quantification of multiple DNA target sequences in one polymerase chain reaction with the input of 20 ng or more DNA but without the requirement of living cells or cell cultures. It can be easily automated and results can be obtained within 30 hours [13] . In MLPA, the probes added to the samples are amplified and quantified [14] . The MLPA kit for rapid aneuploidy diagnosis is commercially available. Both the SALSA MLPA P181-A2 and P182-B1 Centromere kits contain one probe for the short arm and one probe for the long arm of chromosomes other than acrocentric chromosomes, and two probes for the long arm of chromosomes 13 
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Each probe is located close to the centromere of a specific chromosome. The SALSA MLPA Kit P181-A2/P182-B1 Centromere is designed to detect deletions/ duplications of the designated pericentromeric regions of each chromosome. For chromosome 8, the designated regions are FNTA and HOOK3 at 8p11.21, and KIAA0146 and PRKDC at 8q11.21. This MLPA Centromere kit is especially useful for rapid identification of the chromosome origin of an sSMC. In addition to MLPA and SKY, aCGH has the ability to detect DNA dosage imbalance including deletions and duplications in the pericentromeric euchromatic regions and is useful for the characterization of the genomic imbalance in the sSMC.
To date, at least 11 patients with an sSMC (8) An SMC(8) with a duplication of p11.21 q11.1 can be associated with clinical findings. Batanian et al [23] reported a 5-year-old boy with 72% mosaicism for min(8)(:p11.21 q11.1:), attention deficit disorder, seizures and developmental delay. Batanian et al [23] also reported an 11-year-old girl with an SMC (8) or min(8)(:p11.22∼p11.21 q11.1:), anomalous pulmonary venous return, idiopathic thrombocytopenia, precocious puberty and obesity. Anderlid et al [24] reported a 3-year-old boy with 27% mosaicism for r(8)(p10) de novo or r(8)(::p11 q11::), mental retardation and behavior problems. Herry et al [25] reported a 29-year-old man with 76% mosaicism for r(8)(::p11 q11::) and mild intellectual delay but no dysmorphic features. Brecevic et al [26] reported a female infant with 60% mosaicism for r (8) [27] also reported a patient with 47% mosaicism for r(8)(::q10 p11.2::p11.1 q10:) and developmental delay. Liehr [22] reported a 15-year-old boy with SMC(8) or r(8)(::p11.22∼11.21 q11.1::) and atypical autism. Liehr [22] also reported a 3-year-old girl with an SMC(8) or min(8)(:p11.21 q11.1:), developmental and mental retardation, and psychomotor deficiencies.
The present case had a 1-Mb 8p duplication encompassing 8p11.21-p11.1. The duplicated segment contained eight functional genes: CHRNB3, CHRNA6, THAP1, RNF170, HOOK3, FNTA, HGSNAT and A26A1, and seven hypothetical genes: FLJ23356, LOC100131789, LOC643654, LOC347028, LOC1001 28173, LOC100130474 and LOC100130767. The genes CHRNB3 and CHRNA6 are associated with nicotinic acetylcholine receptors. Mutations in the THAP1 gene are related to autosomal dominant torsion dystonia-6. RNF170 is a putative LAG1-interacting ring finger protein.
The Golgi-associated HOOK3 protein is a member of the microtubule-binding proteins. The gene FNTA encodes the α subunit of CAAX farnesyltransferase and HGSNAT encodes heparan-α-glucosaminide N-acetyltransferase, with mutations of HGSNAT associated with an autosomal recessive disorder of mucopolysaccharidosis type IIIC. A26A1 or POTE8 is a prostate-, ovary-, testisexpressed protein on chromosome 8. The present case clinically manifested as multicystic kidney disease and ventriculomegaly but no dysmorphic features. An increase of the genes within the duplicated segment in this case has not previously been reported to be associated with multicystic kidney disease or ventriculomegaly.
With the advent of MLPA, SKY and aCGH, de novo non-acrocentric sSMCs can be well characterized by molecular cytogenetic technologies. We conclude that MLPA, SKY and aCGH are helpful in genetic counseling of prenatally detected sSMCs by providing immediate information on the origin and genetic contents of the sSMC.
